SRPT FY 2019 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$381M+26.5% YoY

Gross Profit

$324M85.1% margin

Operating Income

-$706M-185.3% margin

Net Income

-$715M-187.8% margin

EPS (Diluted)

$-9.71

Cash Flow

Operating Cash Flow

-$456M

Free Cash Flow

-$516M

Stock-Based Comp.

$79M

Balance Sheet

Total Assets

$1.8B

Total Liabilities

$1.0B

Stockholders' Equity

$818M

Cash & Equivalents

$835M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$381M	$301M	+26.5%
Gross Profit	$324M	$267M	+21.5%
Operating Income	-$706M	-$344M	-105.3%
Net Income	-$715M	-$362M	-97.6%